Curis | CRIS - Srodki Pieniężne I Ekwiwalent





Srodki Pieniężne I Ekwiwalent Zmiana Data
Alaunos Therapeutics USD 1.94M 941K 2025-09
Amgen USD 9.13B 316M 2025-12
AstraZeneca USD 8.14B 1.08B 2025-09
Bayer EUR 5.9B 1.34B 2025-09
Bristol-Myers Squibb USD 10.21B 5.52B 2025-12
CSL USD 2.16B 633M 2025-06
Curis USD 10.14M 10.14M 2025-06
Eli Lilly USD 7.27B 2.52B 2025-12
Exelixis USD 482.49M 106.19M 2025-12
Gilead Sciences USD 7.33B 2.19B 2025-09
GlaxoSmithKline GBP 3.3B 303M 2025-09
Incyte USD 3.58B 650.78M 2025-12
Merck USD 18.17B 10.16B 2025-09
Novartis USD 9.56B 2.9B 2025-09
Pfizer USD 1.34B 295M 2025-09
Roche Holding CHF 7.55B 579M 2025-06
Sanofi EUR 7.66B 1.25B 2025-12
Takeda JPY 654.94B 26.55B 2025-12
TG Therapeutics USD 199.51M 21.2M 2025-12
Verastem USD 137.71M 20.14M 2025-09
Xoma USD 143.9M 7.68M 2024-06